$AQST
Aquestive Therapeutics, Inc.

2019 Q4 Form 10-K Financial Statement

#000114036120005499 Filed on March 11, 2020

View on sec.gov

Income Statement

Concept 2019 Q4 2019 Q3 2019 Q2
Revenue $16.42M $12.42M $11.13M
YoY Change -2.41% -6.4% -20.1%
Cost Of Revenue $6.792M $4.643M $5.420M
YoY Change 41.8% -16.94% 9.05%
Gross Profit $9.627M $7.775M $5.709M
YoY Change -20.04% 1.24% -36.28%
Gross Profit Margin 58.63% 62.61% 51.3%
Selling, General & Admin $16.47M $13.71M $16.25M
YoY Change -11.93% 11.08% -51.75%
% of Gross Profit 171.08% 176.39% 284.57%
Research & Development $3.060M $5.063M $8.151M
YoY Change -46.13% 11.67% 1.96%
% of Gross Profit 31.79% 65.12% 142.77%
Depreciation & Amortization $770.0K $695.0K $711.0K
YoY Change 1.32% -5.18% -7.06%
% of Gross Profit 8.0% 8.94% 12.45%
Operating Expenses $26.32M $23.42M $29.82M
YoY Change -9.77% 4.22% -36.03%
Operating Profit -$16.70M -$11.00M -$18.69M
YoY Change -2.55% 19.52% -42.86%
Interest Expense -$2.730M $2.652M $1.937M
YoY Change 71.7% 37.2% 0.52%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income -$12.64M -$18.41M -$20.47M
YoY Change -9.33% 22.44% -43.9%
Income Tax $0.00 $0.00 $0.00
% Of Pretax Income
Net Earnings -$12.64M -$18.41M -$20.47M
YoY Change -9.38% 22.44% -43.9%
Net Earnings / Revenue -76.96% -148.27% -183.95%
Basic Earnings Per Share -$0.74 -$0.82
Diluted Earnings Per Share -$477.9K -$735.5K -$819.5K
COMMON SHARES
Basic Shares Outstanding 25.04M 25.03M 24.98M
Diluted Shares Outstanding

Balance Sheet

Concept 2019 Q4 2019 Q3 2019 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $49.33M $20.91M $22.17M
YoY Change -18.6% -67.32% 108.36%
Cash & Equivalents $49.33M $20.91M $22.17M
Short-Term Investments
Other Short-Term Assets $3.000M $2.710M $2.100M
YoY Change 78.57% 88.19% -58.25%
Inventory $2.859M $4.124M $4.647M
Prepaid Expenses
Receivables $13.13M $10.23M $10.14M
Other Receivables $0.00 $90.00K $10.00K
Total Short-Term Assets $68.31M $38.06M $39.06M
YoY Change -7.93% -50.8% 46.58%
LONG-TERM ASSETS
Property, Plant & Equipment $9.726M $10.35M $10.93M
YoY Change -20.32% -15.23% -14.39%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $286.0K $242.0K $233.0K
YoY Change 19.67% 10.0% 16.5%
Total Long-Term Assets $10.17M $10.76M $11.34M
YoY Change -19.64% -14.96% -14.0%
TOTAL ASSETS
Total Short-Term Assets $68.31M $38.06M $39.06M
Total Long-Term Assets $10.17M $10.76M $11.34M
Total Assets $78.48M $48.82M $50.41M
YoY Change -9.64% -45.76% 26.53%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $12.27M $14.20M $20.03M
YoY Change -39.94% 15.09% 21.27%
Accrued Expenses $5.475M $4.830M $3.270M
YoY Change -23.91% -7.12% -24.65%
Deferred Revenue $806.0K $835.0K $600.0K
YoY Change 11.79%
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $0.00 $0.00 $550.0K
YoY Change -100.0% -100.0% -50.0%
Total Short-Term Liabilities $18.56M $20.05M $24.63M
YoY Change -43.69% -5.99% 4.94%
LONG-TERM LIABILITIES
Long-Term Debt $60.34M $59.78M $46.88M
YoY Change 41.64% 35.71% 3.42%
Other Long-Term Liabilities $1.360M $3.450M $3.550M
YoY Change 11.48% 192.37% -64.46%
Total Long-Term Liabilities $1.360M $63.23M $50.43M
YoY Change -96.9% 39.8% -8.84%
TOTAL LIABILITIES
Total Short-Term Liabilities $18.56M $20.05M $24.63M
Total Long-Term Liabilities $1.360M $63.23M $50.43M
Total Liabilities $84.60M $83.28M $75.07M
YoY Change 10.2% 25.1% -4.73%
SHAREHOLDERS EQUITY
Retained Earnings -$130.5M -$117.8M -$99.43M
YoY Change 112.58%
Common Stock $34.00K $25.00K $25.00K
YoY Change 36.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$6.122M -$34.46M -$24.66M
YoY Change
Total Liabilities & Shareholders Equity $78.48M $48.82M $50.41M
YoY Change -9.64% -45.76% 26.53%

Cashflow Statement

Concept 2019 Q4 2019 Q3 2019 Q2
OPERATING ACTIVITIES
Net Income -$12.64M -$18.41M -$20.47M
YoY Change -9.38% 22.44% -43.9%
Depreciation, Depletion And Amortization $770.0K $695.0K $711.0K
YoY Change 1.32% -5.18% -7.06%
Cash From Operating Activities -$10.57M -$14.79M -$17.17M
YoY Change 276.16% 28.83% -3466.67%
INVESTING ACTIVITIES
Capital Expenditures -$80.00K -$90.00K -$110.0K
YoY Change -83.67% -79.55% -82.54%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$80.00K -$90.00K -$110.0K
YoY Change -83.67% -79.55% -82.54%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $37.30M
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 39.07M 13.63M -490.0K
YoY Change -48937.5% -79.12% -91.45%
NET CHANGE
Cash From Operating Activities -10.57M -14.79M -17.17M
Cash From Investing Activities -80.00K -90.00K -110.0K
Cash From Financing Activities 39.07M 13.63M -490.0K
Net Change In Cash 28.42M -1.250M -17.77M
YoY Change -940.83% -102.34% 203.76%
FREE CASH FLOW
Cash From Operating Activities -$10.57M -$14.79M -$17.17M
Capital Expenditures -$80.00K -$90.00K -$110.0K
Free Cash Flow -$10.49M -$14.70M -$17.06M
YoY Change 352.16% 33.15% -1596.49%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2019 dei Entity Registrant Name
EntityRegistrantName
Aquestive Therapeutics, Inc.
CY2019 dei Entity Central Index Key
EntityCentralIndexKey
0001398733
CY2020Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
33582234
CY2019 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2019
CY2019 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2019 dei Amendment Flag
AmendmentFlag
false
CY2019 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2019 dei Document Period End Date
DocumentPeriodEndDate
2019-12-31
CY2019 dei Entity Address State Or Province
EntityAddressStateOrProvince
NJ
CY2019 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2019 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2019 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2019 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2019Q2 dei Entity Public Float
EntityPublicFloat
101000000
CY2019 dei Document Type
DocumentType
10-K
CY2019 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2019 dei Entity Shell Company
EntityShellCompany
false
CY2019 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
CY2019 dei Entity Ex Transition Period
EntityExTransitionPeriod
false
CY2019 dei Entity Small Business
EntitySmallBusiness
true
CY2018Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
20436000
CY2019Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
12274000
CY2019Q4 us-gaap Asset Retirement Obligations Noncurrent
AssetRetirementObligationsNoncurrent
1360000
CY2019Q4 us-gaap Accounts Receivable Gross
AccountsReceivableGross
9094000
CY2018Q4 us-gaap Accounts Receivable Gross
AccountsReceivableGross
6610000
CY2019Q4 us-gaap Accrued Payroll Taxes Current
AccruedPayrollTaxesCurrent
0
CY2018Q4 us-gaap Accrued Payroll Taxes Current
AccruedPayrollTaxesCurrent
2515000
CY2019Q4 us-gaap Accrued Marketing Costs Current
AccruedMarketingCostsCurrent
1174000
CY2018Q4 us-gaap Accrued Marketing Costs Current
AccruedMarketingCostsCurrent
481000
CY2018Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
7195000
CY2019Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
5475000
CY2019Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
38044000
CY2018Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
35191000
CY2018Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
71431000
CY2019Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
124318000
CY2018 us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
5232000
CY2018 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
116000
CY2019 us-gaap Adjustments To Additional Paid In Capital Stock Issued Ownshare Lending Arrangement Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedOwnshareLendingArrangementIssuanceCosts
-540000
CY2019 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
6723000
CY2018 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2278000
CY2018 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
29940000
CY2019 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
7071000
CY2018 us-gaap Allowance For Doubtful Accounts Receivable Recoveries
AllowanceForDoubtfulAccountsReceivableRecoveries
0
CY2019 us-gaap Allowance For Doubtful Accounts Receivable Recoveries
AllowanceForDoubtfulAccountsReceivableRecoveries
0
CY2018Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
58000
CY2019Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
124000
CY2017Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
55000
CY2019 us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
0
CY2018 us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
50000
CY2019 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
1929000
CY2018 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
1696000
CY2018 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
50000
CY2019 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
51000
CY2019 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1571429
CY2018Q4 us-gaap Asset Retirement Obligations Noncurrent
AssetRetirementObligationsNoncurrent
1216000
CY2017Q4 us-gaap Asset Retirement Obligation
AssetRetirementObligation
1081000
CY2018Q4 us-gaap Asset Retirement Obligation
AssetRetirementObligation
1216000
CY2019Q4 us-gaap Asset Retirement Obligation
AssetRetirementObligation
1360000
CY2018 us-gaap Asset Retirement Obligation Accretion Expense
AssetRetirementObligationAccretionExpense
130000
CY2019 us-gaap Asset Retirement Obligation Accretion Expense
AssetRetirementObligationAccretionExpense
144000
CY2018Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
60599000
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
49326000
CY2018 us-gaap Asset Retirement Obligation Liabilities Incurred
AssetRetirementObligationLiabilitiesIncurred
5000
CY2019 us-gaap Asset Retirement Obligation Liabilities Incurred
AssetRetirementObligationLiabilitiesIncurred
0
CY2018Q4 us-gaap Assets
Assets
86851000
CY2019Q4 us-gaap Assets
Assets
78479000
CY2019Q4 us-gaap Assets Current
AssetsCurrent
68314000
CY2018Q4 us-gaap Assets Current
AssetsCurrent
74201000
CY2019 us-gaap Basis Of Accounting
BasisOfAccounting
<div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;"><tr><td style="width: 45pt; vertical-align: top; color: rgb(0, 0, 0); font-weight: bold;">Note 2.</td><td style="vertical-align: top;"><div style="color: #000000; font-weight: bold;">Basis of Presentation and Principles of Consolidation</div></td></tr></table><div><br /></div><div style="text-indent: 36pt; color: #000000;">These consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States of America, or GAAP, and in accordance with the rules and regulations of the Securities and Exchange Commission, or SEC. The accounts of wholly owned subsidiaries are included in the consolidated financial statements. Other than corporate formation activities, no such subsidiaries have conducted any commercial, developmental or operational activities and none have customers or vendors. Certain reclassifications were made to conform to the current presentation.</div><div><br /></div><div style="text-indent: 36pt; color: #000000;">Any reference in these notes to applicable guidance is meant to refer to the authoritative United States generally accepted principles as found in the Accounting Standards Codification (&#8220;ASC&#8221;) and Accounting Standards Updates (&#8220;ASU&#8221;) of the Financial Accounting Standards Board (&#8220;FASB&#8221;).</div></div>
CY2018 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
43220000
CY2019 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-11273000
CY2017Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
17379000
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
60599000
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
49326000
CY2019Q4 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
2000000
CY2019Q4 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
0.001
CY2018Q4 us-gaap Common Stock Value
CommonStockValue
25000
CY2019Q4 us-gaap Common Stock Value
CommonStockValue
34000
CY2018Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2019Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2018Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2019Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2019Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
33562885
CY2018Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
24957309
CY2018Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
250000000
CY2019Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
250000000
CY2018Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
250000000
CY2018Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
350000000
CY2018Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
25000
CY2018Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
24957309
CY2019Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
33562885
CY2018 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-61376000
CY2019 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-66246000
CY2019 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><div style="color: #000000; font-style: italic; font-weight: bold;">(C) Concentration of Credit Risk</div><div><br /></div><div style="text-indent: 36pt; color: #000000;">Cash and cash equivalents are maintained at one federally insured financial institution. The Company has not experienced any losses in such accounts and management believes that the Company is not exposed to any credit risk due to the financial position of the banking institution.&#160; Indivior is our largest customer, and these details on this relationship are outlined in Note 5.&#160; Indivior does not represent a material credit risk.</div></div>
CY2019Q4 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
4348000
CY2018Q4 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
0
CY2018Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
721000
CY2019Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
806000
CY2019Q3 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
70000000
CY2018Q4 us-gaap Deferred Tax Liabilities Prepaid Expenses
DeferredTaxLiabilitiesPrepaidExpenses
407000
CY2019Q4 us-gaap Deferred Tax Liabilities Prepaid Expenses
DeferredTaxLiabilitiesPrepaidExpenses
0
CY2018Q4 us-gaap Deferred Tax Assets Property Plant And Equipment
DeferredTaxAssetsPropertyPlantAndEquipment
1380000
CY2019Q4 us-gaap Deferred Tax Assets Property Plant And Equipment
DeferredTaxAssetsPropertyPlantAndEquipment
1741000
CY2019Q4 us-gaap Deferred Offering Costs
DeferredOfferingCosts
149000
CY2019Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
58000
CY2018Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
446000
CY2018Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
19955000
CY2019Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
40115000
CY2018Q4 us-gaap Deferred Tax Assets Inventory
DeferredTaxAssetsInventory
120000
CY2019Q4 us-gaap Deferred Tax Assets Inventory
DeferredTaxAssetsInventory
69000
CY2018Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
0
CY2019Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
0
CY2019Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
23687000
CY2018Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
10899000
CY2019Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
783000
CY2018Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
260000
CY2018Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards
DeferredTaxAssetsTaxCreditCarryforwards
3917000
CY2019Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards
DeferredTaxAssetsTaxCreditCarryforwards
4621000
CY2019Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals
835000
CY2018Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals
15000
CY2018Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
1224000
CY2019Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
2505000
CY2018Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
19509000
CY2019Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
40057000
CY2019Q4 us-gaap Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets
DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets
58000
CY2018Q4 us-gaap Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets
DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets
39000
CY2018 us-gaap Defined Benefit Plan Contributions By Employer
DefinedBenefitPlanContributionsByEmployer
837000
CY2019 us-gaap Defined Benefit Plan Contributions By Employer
DefinedBenefitPlanContributionsByEmployer
819000
CY2018 us-gaap Depreciation And Amortization
DepreciationAndAmortization
3236000
CY2019 us-gaap Depreciation And Amortization
DepreciationAndAmortization
2905000
CY2018 us-gaap Depreciation
Depreciation
3186000
CY2019 us-gaap Depreciation
Depreciation
2854000
CY2018 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-2.96
CY2018Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
204000
CY2018 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.2724
CY2019Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
153000
CY2019 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.3102
CY2018Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
2663000
CY2019Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
2714000
CY2019 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-2.61
CY2019Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.74
CY2018Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
0.27
CY2018Q4 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.56
CY2018Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-1.90
CY2019Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.82
CY2019Q4 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.48
CY2019Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.59
CY2018Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.64
CY2018 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.2100
CY2019 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.2100
CY2018 us-gaap Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate
EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate
0
CY2019 us-gaap Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate
EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate
0
CY2018 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.0704
CY2019 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.0676
CY2019 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0
CY2018 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0
CY2019 us-gaap Effective Income Tax Rate Reconciliation Tax Credits Research
EffectiveIncomeTaxRateReconciliationTaxCreditsResearch
0.0232
CY2018 us-gaap Effective Income Tax Rate Reconciliation Tax Credits Research
EffectiveIncomeTaxRateReconciliationTaxCreditsResearch
0.0440
CY2019Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
3758000
CY2018Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
3604000
CY2018 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
5278000
CY2019 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
0
CY2019Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
2867000
CY2018Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
2867000
CY2019Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
50000
CY2019Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
50000
CY2019Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
50000
CY2018 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0
CY2019 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-4896000
CY2019 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-2582000
CY2018 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
1427000
CY2018 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
1140000
CY2019 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
1366000
CY2019 us-gaap Interest And Other Income
InterestAndOtherIncome
636000
CY2018 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-61376000
CY2019 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-66246000
CY2018 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2019 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2019 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-7872000
CY2018 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
11319000
CY2019 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
746000
CY2018 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
281000
CY2018 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-626000
CY2019 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
1601000
CY2019 us-gaap Increase Decrease In Accounts And Other Receivables
IncreaseDecreaseInAccountsAndOtherReceivables
6815000
CY2018 us-gaap Increase Decrease In Accounts And Other Receivables
IncreaseDecreaseInAccountsAndOtherReceivables
409000
CY2018 us-gaap Interest And Other Income
InterestAndOtherIncome
552000
CY2018 us-gaap Interest Expense
InterestExpense
7711000
CY2019 us-gaap Interest Expense
InterestExpense
9318000
CY2018 us-gaap Interest Paid Net
InterestPaidNet
6049000
CY2019 us-gaap Interest Paid Net
InterestPaidNet
7340000
CY2019Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
519000
CY2018Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
1183000
CY2018Q4 us-gaap Liabilities
Liabilities
76771000
CY2019Q4 us-gaap Liabilities
Liabilities
84601000
CY2019Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
1244000
CY2018Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
1283000
CY2018Q4 us-gaap Inventory Net
InventoryNet
5441000
CY2019Q4 us-gaap Inventory Net
InventoryNet
2859000
CY2018Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
86851000
CY2019Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
78479000
CY2018Q4 us-gaap Liabilities Current
LiabilitiesCurrent
32952000
CY2019Q4 us-gaap Liabilities Current
LiabilitiesCurrent
18555000
CY2019Q4 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
0
CY2018Q4 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
4600000
CY2019Q4 us-gaap Long Term Debt
LongTermDebt
70000000
CY2019Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
17500000
CY2019Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
0
CY2019Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
10500000
CY2019Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
3500000
CY2019Q4 us-gaap Long Term Debt Maturities Repayments Of Principal After Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive
38500000
CY2018Q4 us-gaap Long Term Loans Payable
LongTermLoansPayable
42603000
CY2019Q4 us-gaap Long Term Loans Payable
LongTermLoansPayable
60338000
CY2013Q3 us-gaap Loss Contingency Number Of Defendants
LossContingencyNumberOfDefendants
6
CY2019 us-gaap Loss Contingency Claims Settled Number
LossContingencyClaimsSettledNumber
3
CY2019 us-gaap Loss Contingency New Claims Filed Number
LossContingencyNewClaimsFiledNumber
4
CY2019Q4 us-gaap Loss Contingency Pending Claims Number
LossContingencyPendingClaimsNumber
2
CY2018Q3 us-gaap Net Income Loss
NetIncomeLoss
-15038000
CY2019 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-60210000
CY2018 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-12991000
CY2018 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1824000
CY2019 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-663000
CY2019 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
49600000
CY2018 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
58035000
CY2018 us-gaap Net Income Loss
NetIncomeLoss
-61376000
CY2019 us-gaap Net Income Loss
NetIncomeLoss
-66246000
CY2019Q3 us-gaap Net Income Loss
NetIncomeLoss
-18412000
CY2018Q4 us-gaap Net Income Loss
NetIncomeLoss
-13944000
CY2019Q1 us-gaap Net Income Loss
NetIncomeLoss
-14726000
CY2018Q1 us-gaap Net Income Loss
NetIncomeLoss
4099000
CY2018Q2 us-gaap Net Income Loss
NetIncomeLoss
-36493000
CY2019Q2 us-gaap Net Income Loss
NetIncomeLoss
-20472000
CY2019Q4 us-gaap Net Income Loss
NetIncomeLoss
-12636000
CY2019 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
1613000
CY2018 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
1393000
CY2018 us-gaap Operating Expenses
OperatingExpenses
116369000
CY2019 us-gaap Operating Expenses
OperatingExpenses
105277000
CY2018Q2 us-gaap Operating Expenses
OperatingExpenses
46614000
CY2019Q1 us-gaap Operating Expenses
OperatingExpenses
25717000
CY2018Q3 us-gaap Operating Expenses
OperatingExpenses
22471000
CY2019Q2 us-gaap Operating Expenses
OperatingExpenses
29817000
CY2019Q3 us-gaap Operating Expenses
OperatingExpenses
23420000
CY2019Q4 us-gaap Operating Expenses
OperatingExpenses
26323000
CY2018Q4 us-gaap Operating Expenses
OperatingExpenses
29173000
CY2018Q1 us-gaap Operating Expenses
OperatingExpenses
18106000
CY2018 us-gaap Operating Income Loss
OperatingIncomeLoss
-48934000
CY2019 us-gaap Operating Income Loss
OperatingIncomeLoss
-52668000
CY2019Q4 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
1287000
CY2019Q4 us-gaap Operating Leases Future Minimum Payments Due In Four Years
OperatingLeasesFutureMinimumPaymentsDueInFourYears
380000
CY2019Q4 us-gaap Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
1153000
CY2019Q4 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
4094000
CY2019Q4 us-gaap Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
1274000
CY2019Q4 us-gaap Operating Leases Future Minimum Payments Due Thereafter
OperatingLeasesFutureMinimumPaymentsDueThereafter
0
CY2019Q4 us-gaap Other Receivables Gross Current
OtherReceivablesGrossCurrent
4363000
CY2018Q4 us-gaap Other Receivables Gross Current
OtherReceivablesGrossCurrent
33000
CY2018Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
239000
CY2019Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
286000
CY2018Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
207000
CY2019Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
243000
CY2019 us-gaap Paid In Kind Interest
PaidInKindInterest
359000
CY2019 us-gaap Payments Of Debt Extinguishment Costs
PaymentsOfDebtExtinguishmentCosts
2944000
CY2018 us-gaap Payments Of Debt Extinguishment Costs
PaymentsOfDebtExtinguishmentCosts
0
CY2019 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
2827000
CY2018 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
6027000
CY2018 us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
4768000
CY2019 us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
3946000
CY2019 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
663000
CY2018 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1824000
CY2018 us-gaap Paid In Kind Interest
PaidInKindInterest
237000
CY2019Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
2999000
CY2018Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1680000
CY2019 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
1821000
CY2018 us-gaap Proceeds From Issuance Of Debt
ProceedsFromIssuanceOfDebt
0
CY2019 us-gaap Proceeds From Issuance Of Debt
ProceedsFromIssuanceOfDebt
70000000
CY2019Q4 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
37295000
CY2019 us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
39317000
CY2018 us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
68830000
CY2018Q3 us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
63482000
CY2019Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
47770000
CY2018Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
47398000
CY2018Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
12207000
CY2019Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
9726000
CY2018 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
23112000
CY2018Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-61376000
CY2018 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
53000
CY2019 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
66000
CY2018 us-gaap Repayments Of Debt
RepaymentsOfDebt
0
CY2019 us-gaap Repayments Of Debt
RepaymentsOfDebt
50000000
CY2019Q3 us-gaap Repayments Of Debt
RepaymentsOfDebt
50000000
CY2019 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
20574000
CY2019Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-130474000
CY2019 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
52609000
CY2018 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
67430000
CY2018Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
23411000
CY2018Q4 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
16824000
CY2019Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
12418000
CY2019Q4 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
16419000
CY2018Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
13928000
CY2018Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
13267000
CY2019Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
11129000
CY2019Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
12643000
CY2018 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
72269000
CY2019 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
64342000
CY2018 us-gaap Share Based Compensation
ShareBasedCompensation
29940000
CY2019 us-gaap Share Based Compensation
ShareBasedCompensation
7071000
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
1700000
CY2019Q4 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
8050000
CY2019 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
237000
CY2018 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
68714000
CY2019 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
37835000
CY2018 us-gaap Stock Issued During Period Value Employee Stock Ownership Plan
StockIssuedDuringPeriodValueEmployeeStockOwnershipPlan
19123000
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
10080000
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
-6122000
CY2017Q4 us-gaap Stockholders Equity
StockholdersEquity
-26495000
CY2019 aqst Adjustments To Additional Paid In Capital Fair Value Of Warrants Issued
AdjustmentsToAdditionalPaidInCapitalFairValueOfWarrantsIssued
6800000
CY2018Q3 us-gaap Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
12.34
CY2019Q4 us-gaap Taxes Payable Current
TaxesPayableCurrent
300000
CY2018Q4 us-gaap Taxes Payable Current
TaxesPayableCurrent
388000
CY2019Q4 aqst Tax Cuts And Jobs Act Of2017 Deferred Tax Assets Interest Limitation
TaxCutsAndJobsActOf2017DeferredTaxAssetsInterestLimitation
5748000
CY2018Q4 aqst Tax Cuts And Jobs Act Of2017 Deferred Tax Assets Interest Limitation
TaxCutsAndJobsActOf2017DeferredTaxAssetsInterestLimitation
2124000
CY2018Q4 aqst Deferred Tax Assets Accounts Receivable
DeferredTaxAssetsAccountsReceivable
16000
CY2019Q4 aqst Deferred Tax Assets Accounts Receivable
DeferredTaxAssetsAccountsReceivable
126000
CY2018Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2019Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2019Q4 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
0
CY2018Q4 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
0
CY2019 us-gaap Use Of Estimates
UseOfEstimates
<div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><div style="color: #000000; font-style: italic; font-weight: bold;">(A) Use of Estimates</div><div><br /></div><div style="text-indent: 36pt; color: #000000;">The preparation of financial statements in conformity with U.S. GAAP requires the use of estimates and assumptions that affect the reported amounts of assets and liabilities, including disclosure of contingent assets and contingent liabilities, at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. These estimates and assumptions often involve assessments of matters that are inherently uncertain and accordingly actual results could differ from those estimates.&#160; <font style="background-color: #FFFFFF;">Significant items subject to estimates and assumptions include those related to revenue recognition, inventory costs, allowances for rebates from proprietary product sales, allowances for sales returns, the useful lives of fixed assets, the valuations of warrants issued and of share-based compensation, and contingencies.</font></div></div>
CY2019 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
25356098
CY2018 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
20725526
CY2019Q4 aqst Number Of States In The Antitrust Litigation
NumberOfStatesInTheAntitrustLitigation
41
CY2019 aqst Number Of Patents
NumberOfPatents
2
CY2018 aqst Effective Income Tax Rate Reconciliation Permanent Differences Percent
EffectiveIncomeTaxRateReconciliationPermanentDifferencesPercent
-0.0709
CY2019 aqst Effective Income Tax Rate Reconciliation Permanent Differences Percent
EffectiveIncomeTaxRateReconciliationPermanentDifferencesPercent
-0.0004
CY2019 aqst Effective Income Tax Rate Reconciliation Effect Of State Rate Change Percent
EffectiveIncomeTaxRateReconciliationEffectOfStateRateChangePercent
0.0000
CY2018 aqst Effective Income Tax Rate Reconciliation Effect Of State Rate Change Percent
EffectiveIncomeTaxRateReconciliationEffectOfStateRateChangePercent
0.0041
CY2018 aqst Effective Income Tax Rate Reconciliation Tax Credit Return To Provision Percent
EffectiveIncomeTaxRateReconciliationTaxCreditReturnToProvisionPercent
0.0148
CY2019 aqst Effective Income Tax Rate Reconciliation Tax Credit Return To Provision Percent
EffectiveIncomeTaxRateReconciliationTaxCreditReturnToProvisionPercent
0.0098
CY2018 aqst Stock Issued During Period Values Stock Splits
StockIssuedDuringPeriodValuesStockSplits
0
CY2018 aqst Adjustments To Additional Paid In Capital Reclassification Of Warrant Liability To Equity
AdjustmentsToAdditionalPaidInCapitalReclassificationOfWarrantLiabilityToEquity
12952000
CY2018 aqst Noncash Exercise Of Warrants
NoncashExerciseOfWarrants
12952000
CY2019 aqst Noncash Exercise Of Warrants
NoncashExerciseOfWarrants
0
CY2019 aqst Deferred Financing Costs Charged To Additional Paid In Capital
DeferredFinancingCostsChargedToAdditionalPaidInCapital
540000
CY2018 aqst Deferred Financing Costs Charged To Additional Paid In Capital
DeferredFinancingCostsChargedToAdditionalPaidInCapital
5232000
CY2019 aqst Payments Related To Tax Withholding For Share Based Compensation Accrued
PaymentsRelatedToTaxWithholdingForShareBasedCompensationAccrued
0
CY2018 aqst Payments Related To Tax Withholding For Share Based Compensation Accrued
PaymentsRelatedToTaxWithholdingForShareBasedCompensationAccrued
2515000
CY2018 aqst Increase Decrease In Offering Costs Included In Accounts Payable And Accrued Expenses
IncreaseDecreaseInOfferingCostsIncludedInAccountsPayableAndAccruedExpenses
-588000
CY2019 aqst Increase Decrease In Offering Costs Included In Accounts Payable And Accrued Expenses
IncreaseDecreaseInOfferingCostsIncludedInAccountsPayableAndAccruedExpenses
0
CY2019 aqst Increase Decrease In Capital Expenditures Included In Accounts Payable And Accrued Expenses
IncreaseDecreaseInCapitalExpendituresIncludedInAccountsPayableAndAccruedExpenses
104000
CY2018 aqst Increase Decrease In Capital Expenditures Included In Accounts Payable And Accrued Expenses
IncreaseDecreaseInCapitalExpendituresIncludedInAccountsPayableAndAccruedExpenses
104000
CY2019 aqst Warrants Issued In Connection With Long Term Debt
WarrantsIssuedInConnectionWithLongTermDebt
6800000
CY2018 aqst Warrants Issued In Connection With Long Term Debt
WarrantsIssuedInConnectionWithLongTermDebt
0
CY2018 aqst Asset Retirement Obligations Depreciation Expense
AssetRetirementObligationsDepreciationExpense
27000
CY2019 aqst Asset Retirement Obligations Depreciation Expense
AssetRetirementObligationsDepreciationExpense
24000
CY2019Q3 aqst Additional Fund Amount
AdditionalFundAmount
13110000
CY2019Q4 aqst Working Capital Deficit
WorkingCapitalDeficit
49759000
CY2019 aqst Adjustments To Additional Paid In Capital Warrant Exercise
AdjustmentsToAdditionalPaidInCapitalWarrantExercise
1821000
CY2019Q4 aqst Adjustments To Additional Paid In Capital Warrant Exercise
AdjustmentsToAdditionalPaidInCapitalWarrantExercise
1821000
CY2018Q4 aqst Inventory Packing Material Gross
InventoryPackingMaterialGross
2975000
CY2019Q4 aqst Inventory Packing Material Gross
InventoryPackingMaterialGross
1096000
CY2019Q3 aqst Net Proceeds From Issuance Of Initial Notes Warrants And First Offer Rights
NetProceedsFromIssuanceOfInitialNotesWarrantsAndFirstOfferRights
66082000
CY2019Q4 aqst Finite Lived Intangible Assets Net And Other Assets
FiniteLivedIntangibleAssetsNetAndOtherAssets
439000
CY2018Q4 aqst Finite Lived Intangible Assets Net And Other Assets
FiniteLivedIntangibleAssetsNetAndOtherAssets
443000
CY2019 aqst Manufacture And Supply Costs
ManufactureAndSupplyCosts
20361000
CY2018 aqst Manufacture And Supply Costs
ManufactureAndSupplyCosts
20988000
CY2018Q2 aqst Manufacture And Supply Costs
ManufactureAndSupplyCosts
4973000
CY2019Q2 aqst Manufacture And Supply Costs
ManufactureAndSupplyCosts
5420000
CY2018Q3 aqst Manufacture And Supply Costs
ManufactureAndSupplyCosts
5592000
CY2019Q1 aqst Manufacture And Supply Costs
ManufactureAndSupplyCosts
3506000
CY2019Q3 aqst Manufacture And Supply Costs
ManufactureAndSupplyCosts
4643000
CY2018Q1 aqst Manufacture And Supply Costs
ManufactureAndSupplyCosts
5636000
CY2019Q4 aqst Manufacture And Supply Costs
ManufactureAndSupplyCosts
6792000
CY2018Q4 aqst Manufacture And Supply Costs
ManufactureAndSupplyCosts
4787000
CY2019Q4 aqst Trade And Other Receivables Net
TradeAndOtherReceivablesNet
13130000
CY2018Q4 aqst Trade And Other Receivables Net
TradeAndOtherReceivablesNet
6481000
CY2018Q4 aqst Accounts Receivable Allowances And Accruals Trade And Other Receivables Net
AccountsReceivableAllowancesAndAccrualsTradeAndOtherReceivablesNet
104000
CY2019Q4 aqst Accounts Receivable Allowances And Accruals Trade And Other Receivables Net
AccountsReceivableAllowancesAndAccrualsTradeAndOtherReceivablesNet
203000
CY2019 aqst Accounts Receivable Allowances Credits And Payments
AccountsReceivableAllowancesCreditsAndPayments
145000
CY2018 aqst Accounts Receivable Allowances Credits And Payments
AccountsReceivableAllowancesCreditsAndPayments
0
CY2017Q4 aqst Accounts Receivable Allowances And Accruals
AccountsReceivableAllowancesAndAccruals
0
CY2019Q4 aqst Accounts Receivable Allowances And Accruals
AccountsReceivableAllowancesAndAccruals
203000
CY2019 aqst Accounts Receivable Allowances Provision Related To Sales
AccountsReceivableAllowancesProvisionRelatedToSales
244000
CY2018 aqst Accounts Receivable Allowances Provision Related To Sales
AccountsReceivableAllowancesProvisionRelatedToSales
104000
CY2018Q4 aqst Accounts Receivable Allowances And Accruals
AccountsReceivableAllowancesAndAccruals
104000

Files In Submission

Name View Source Status
0001140361-20-005499-index-headers.html Edgar Link pending
0001140361-20-005499-index.html Edgar Link pending
0001140361-20-005499.txt Edgar Link pending
0001140361-20-005499-xbrl.zip Edgar Link pending
aqst-20191231.xml Edgar Link completed
aqst-20191231.xsd Edgar Link pending
aqst-20191231_cal.xml Edgar Link unprocessable
aqst-20191231_def.xml Edgar Link unprocessable
aqst-20191231_lab.xml Edgar Link unprocessable
aqst-20191231_pre.xml Edgar Link unprocessable
ex10_14.htm Edgar Link pending
ex23_1.htm Edgar Link pending
ex31_1.htm Edgar Link pending
ex31_2.htm Edgar Link pending
ex32_1.htm Edgar Link pending
ex32_2.htm Edgar Link pending
ex4_7.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
form10k.htm Edgar Link pending
image00005.jpg Edgar Link pending
image02.jpg Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending